LUMO logo

Lumos Pharma (LUMO) Depreciation And Amortization

Annual D&A

$44.00 K
-$5000.00-10.20%

31 December 2023

3-Year Change

-79.72%
LUMO annual depreciation & amortization is down -79.72% over the past 3 years

All-time High

$2.08 M
LUMO annual depreciation & amortization is currently -97.89% below its historical high of $2.08 million
Annual Total Expenses$38.66 M
LUMO annual total expenses is $38.66 million
Annual Operating Expenses$38.66 M
LUMO annual total operating expenses is $38.66 million
Annual Revenue$2.05 M
LUMO annual revenue is $2.05 million
Annual Net Income-$34.03 M
LUMO annual net profit is -$34.03 million

LUMO Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

-$1000.00
-$3000.00-150.00%

30 September 2024

1-Year Change

-105.56%
LUMO quarterly depreciation & amortization is down -105.56% year-on-year

3-Year Change

-103.85%
LUMO quarterly depreciation & amortization is down -103.85% over the past 3 years

All-time High

$609.00 K
LUMO quarterly depreciation & amortization is currently -100.16% below its historical high of $609.00 thousand
Quarterly Total Expenses$8.37 M
LUMO quarterly total expenses is $8.37 million
Quarterly Operating Expenses$8.37 M
LUMO quarterly total operating expenses is $8.37 million
Quarterly Revenue$726.00 K
LUMO quarterly revenue is $726.00 thousand
Quarterly Net Income-$7.47 M
LUMO quarterly net profit is -$7.47 million

LUMO Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

$21.00 K
-$9000.00-30.00%

30 September 2024

1-Year Change

-52.27%
LUMO TTM depreciation & amortization is down -52.27% year-on-year

3-Year Change

-90.32%
LUMO TTM depreciation & amortization is down -90.32% over the past 3 years

All-time High

$2.17 M
LUMO TTM depreciation & amortization is currently -99.03% below its historical high of $2.17 million
Annual Total Expenses$38.66 M
LUMO annual total expenses is $38.66 million
Annual Operating Expenses$38.66 M
LUMO annual total operating expenses is $38.66 million
TTM Revenue$2.21 M
LUMO TTM revenue is $2.21 million
TTM Net Income-$34.92 M
LUMO TTM net profit is -$34.92 million

LUMO TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LUMO Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year--105.6%-52.3%
3 y3 years-79.7%-103.8%-90.3%
5 y5 years+18.9%-107.1%-43.2%

LUMO Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-97.9%-100.2%-99.0%

Lumos Pharma Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2024
-
-$1000.00(-150.0%)
$21.00 K(-30.0%)
June 2024
-
$2000.00(0.0%)
$30.00 K(-18.9%)
Mar 2024
-
$2000.00(-88.9%)
$37.00 K(-15.9%)
Dec 2023
$44.00 K(-10.2%)
$18.00 K(+125.0%)
$44.00 K(-27.9%)
Sept 2023
-
$8000.00(-11.1%)
$61.00 K(+7.0%)
June 2023
-
$9000.00(0.0%)
$57.00 K(+23.9%)
Mar 2023
-
$9000.00(-74.3%)
$46.00 K(-6.1%)
Dec 2022
$49.00 K(-77.4%)
$35.00 K(+775.0%)
$49.00 K(+22.5%)
Sept 2022
-
$4000.00(-300.0%)
$40.00 K(+5.3%)
June 2022
-
-$2000.00(-116.7%)
$38.00 K(-35.6%)
Mar 2022
-
$12.00 K(-53.8%)
$59.00 K(-72.8%)
Dec 2021
$217.00 K(-62.8%)
$26.00 K(+1200.0%)
$217.00 K(-45.8%)
Sept 2021
-
$2000.00(-89.5%)
$400.00 K(-27.7%)
June 2021
-
$19.00 K(-88.8%)
$553.00 K(-25.8%)
Mar 2021
-
$170.00 K(-18.7%)
$745.00 K(+27.6%)
Dec 2020
$584.00 K(+1478.4%)
$209.00 K(+34.8%)
$584.00 K(+50.1%)
Sept 2020
-
$155.00 K(-26.5%)
$389.00 K(+64.1%)
June 2020
-
$211.00 K(+2244.4%)
$237.00 K(+577.1%)
Mar 2020
-
$9000.00(-35.7%)
$35.00 K(-5.4%)
Dec 2019
$37.00 K(-96.8%)
$14.00 K(+366.7%)
$37.00 K(-86.1%)
Sept 2019
-
$3000.00(-66.7%)
$267.00 K(-49.4%)
June 2019
-
$9000.00(-18.2%)
$528.00 K(-35.8%)
Mar 2019
-
$11.00 K(-95.5%)
$822.00 K(-28.2%)
Dec 2018
$1.15 M(-18.6%)
$244.00 K(-7.6%)
$1.15 M(-8.0%)
Sept 2018
-
$264.00 K(-12.9%)
$1.24 M(-7.0%)
June 2018
-
$303.00 K(-9.3%)
$1.34 M(-3.2%)
Mar 2018
-
$334.00 K(-2.6%)
$1.38 M(-1.8%)
Dec 2017
$1.41 M
$343.00 K(-3.9%)
$1.41 M(-12.7%)
Sept 2017
-
$357.00 K(+2.9%)
$1.61 M(+1.6%)
DateAnnualQuarterlyTTM
June 2017
-
$347.00 K(-3.6%)
$1.59 M(-14.2%)
Mar 2017
-
$360.00 K(-34.3%)
$1.85 M(-11.3%)
Dec 2016
$2.08 M(+30.9%)
$548.00 K(+65.1%)
$2.08 M(+1.3%)
Sept 2016
-
$332.00 K(-45.5%)
$2.06 M(-5.2%)
June 2016
-
$609.00 K(+2.4%)
$2.17 M(+15.2%)
Mar 2016
-
$595.00 K(+14.2%)
$1.88 M(+18.3%)
Dec 2015
$1.59 M(+45.1%)
$521.00 K(+17.3%)
$1.59 M(+17.6%)
Sept 2015
-
$444.00 K(+37.5%)
$1.35 M(+12.2%)
June 2015
-
$323.00 K(+6.3%)
$1.21 M(+5.4%)
Mar 2015
-
$304.00 K(+7.4%)
$1.15 M(+4.4%)
Dec 2014
$1.10 M(+23.1%)
$283.00 K(-4.7%)
$1.10 M(+2.5%)
Sept 2014
-
$297.00 K(+13.8%)
$1.07 M(+8.9%)
June 2014
-
$261.00 K(+2.0%)
$983.00 K(+5.1%)
Mar 2014
-
$256.00 K(0.0%)
$935.00 K(+4.9%)
Dec 2013
$891.00 K(+13.1%)
$256.00 K(+21.9%)
$891.00 K(+4.8%)
Sept 2013
-
$210.00 K(-1.4%)
$850.00 K(+1.1%)
June 2013
-
$213.00 K(+0.5%)
$841.00 K(+1.9%)
Mar 2013
-
$212.00 K(-1.4%)
$825.00 K(+4.7%)
Dec 2012
$788.00 K(+14.7%)
$215.00 K(+7.0%)
$788.00 K(+6.5%)
Sept 2012
-
$201.00 K(+2.0%)
$740.00 K(+4.1%)
June 2012
-
$197.00 K(+12.6%)
$711.00 K(+3.3%)
Mar 2012
-
$175.00 K(+4.8%)
$688.00 K(+0.1%)
Dec 2011
$687.00 K(+4.9%)
$167.00 K(-2.9%)
$687.00 K(+32.1%)
Sept 2011
-
$172.00 K(-1.1%)
$520.00 K(+49.4%)
June 2011
-
$174.00 K(0.0%)
$348.00 K(+100.0%)
Mar 2011
-
$174.00 K
$174.00 K
Dec 2010
$655.00 K(+116.2%)
-
-
Dec 2009
$303.00 K(+3.1%)
-
-
Dec 2008
$294.00 K
-
-

FAQ

  • What is Lumos Pharma annual depreciation & amortization?
  • What is the all time high annual D&A for Lumos Pharma?
  • What is Lumos Pharma quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Lumos Pharma?
  • What is Lumos Pharma quarterly D&A year-on-year change?
  • What is Lumos Pharma TTM depreciation & amortization?
  • What is the all time high TTM D&A for Lumos Pharma?
  • What is Lumos Pharma TTM D&A year-on-year change?

What is Lumos Pharma annual depreciation & amortization?

The current annual D&A of LUMO is $44.00 K

What is the all time high annual D&A for Lumos Pharma?

Lumos Pharma all-time high annual depreciation & amortization is $2.08 M

What is Lumos Pharma quarterly depreciation & amortization?

The current quarterly D&A of LUMO is -$1000.00

What is the all time high quarterly D&A for Lumos Pharma?

Lumos Pharma all-time high quarterly depreciation & amortization is $609.00 K

What is Lumos Pharma quarterly D&A year-on-year change?

Over the past year, LUMO quarterly depreciation & amortization has changed by -$19.00 K (-105.56%)

What is Lumos Pharma TTM depreciation & amortization?

The current TTM D&A of LUMO is $21.00 K

What is the all time high TTM D&A for Lumos Pharma?

Lumos Pharma all-time high TTM depreciation & amortization is $2.17 M

What is Lumos Pharma TTM D&A year-on-year change?

Over the past year, LUMO TTM depreciation & amortization has changed by -$23.00 K (-52.27%)